Skip to content

Lakewood-Amedex Biotherapeutics Inc.

LABT

CIK 0002079272 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
—
Q1 Mar 2026
Net Income (TTM)
—
Q1 Mar 2026
EPS Diluted (TTM)
—
Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
—
Q1 Mar 2026
Net Margin
—
Q1 Mar 2026
Free Cash Flow (TTM)
—
Q1 Mar 2026
Cash
$11.71K
Q1 Mar 2026
Total Debt
—
Q1 Mar 2026
Shares Outstanding
7M sh
Q1 Mar 2026

Recent filings